Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated group A streptococci

Infection and Immunity

Volumn 71, Issue 1, 2003, Pages 446-455

  Sierig, Gabriele ^a,c   Cywes, Colette ^a   Wessels, Michael R ^a,b   Ashbaugh, Cameron D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; STREPTOLYSIN O; STREPTOLYSIN S;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PERITONITIS; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPSIS; SOFT TISSUE INFECTION; STREPTOCOCCUS GROUP A;

ANIMALS; BACTERIAL CAPSULES; BACTERIAL PROTEINS; FEMALE; GENE DELETION; HEMOLYSIS; HUMANS; KERATINOCYTES; MICE; NEUTROPHILS; PHAGOCYTOSIS; SEPSIS; SOFT TISSUE INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; STREPTOLYSINS; VIRULENCE;

EID: 0037222981     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.1.446-455.2003     Document Type: Article

References (42)

1. Alouf, J. E. 1980. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol. Ther. 11:661-717.
2. Altman, D. G. 1991. Practical Statistics for Medical Research, 1st Ed. Chapman and Hall, New York, N.Y.
3. Andersen, B. R., and J. L. Duncan. 1980. Activation of human neutrophil metabolism by streptolysin O. J. Infect. Dis. 141:680-685.
4. Anderson, B. R., and D. F. VanEpps. 1980. Suppression of chemotactic activity of human neutrophils by streptolysin O. J. Infect. Dis. 125:353-359.
5. Ashbaugh, C. D., T. J. Moser, M. H. Shearer, G. L. White, R. C. Kennedy, and M. R. Wessels. 2000. Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal infection. Cell. Microbiol. 2:283-292.
6. Ashbaugh, C. D., H. B. Warren, V. J. Carey, and M. R. Wessels. 1998. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J. Clin. Investig. 102:550-560.
7. Ashbaugh, C. D., and M. R. Wessels. 2001. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group a streptococcal infection. Infect. Immun. 69:6683-6688.
8. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current Protocols in Molecular Biology. John Wiley & Sons, New York, N.Y.
9. Bernheimer, A. W. 1949. Formation of a bacterial toxin (streptolysin S) by resting cells. J. Exp. Med. 90:373-392.
10. Bernheimer, A. W., and L. L. Schwartz. 1964. Lysosomal disruption by bacterial toxins. J. Bacteriol. 87:1100-1104.
11. Betschel, S. D., S. M. Borgia, N. L. Barg, D. E. Low, and J. C. S. De Azavedo. 1998. Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect. Immun. 66:1671-1679.
12. Biswas, I., P. Germon, K. McDade, and J. R. Scott. 2001. Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. Infect. Immun. 69:7029-7038.
13. +-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci. Mol. Microbiol. 44:257-269.
14. Davies, H. D., A. McGeer, B. Schwartz, K. Green, D. Cann, A. E. Simor, D. E. Low, and the Ontario Group A Streptococcal Study Group. 1996. Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med. 335:547-554.
15. Ginsburg, I. 1972. Microbial Toxins, p. 99-171. Academic Press, New York, N.Y.
16. Ginsburg, I. 1972. Mechanism of cell and tissue injury by group A streptococci: relation to poststreptococcal sequelae. J. Infect. Dis. 126:294-456.
17. Herbert, D., and E. W. Todd. 1944. The oxygen-stable haemolysin of group A haemolytic streptococci (streptolysin S). Br. J. Exp. Pathol. 25:242-254.
18. Hirsch, J. G., A. W. Bernheimer, and G. Weissman. 1963. Motion picture study of the toxic action of streptolysins on leukocytes. J. Exp. Med. 118: 223-227.
19. Hryniewicz, W., and J. Pryjma. 1977. Effect of streptolysin S on human and mouse T and B lymphocytes. Infect. Immun. 16:730-733.
20. Keiser, H., G. Weissman, and A. W. Bernheimer. 1964. Studies on lysosomes. IV. Solubilization of enzymes during mitochondrial swelling and disruption of lysosomes by streptolysin S and other hemolytic agents. J. Cell Biol. 22:101-113.
21. Lancefield, R. 1957. Differentiation of group A streptococci with a common R antigen into three serological types with special reference to the bactericidal test. J. Exp. Med. 107:525-544.
22. Lancefield, R. C. 1962. Current knowledge of the type specific M antigens of group A streptococci. J. Immunol. 89:307-313.
23. Lawless, J. F. 1982. Statistical Models and Methods for Lifetime Data. J. Wiley, New York, N.Y.
24. Limbago, B., V. Penumalli, B. Weinrick, and J. R. Scott. 2000. Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect. Immun. 68:6384-6390.
25. Loridan, C., and J. E. Alouf. 1986. Purification of RNA-core induced streptolysin S, and isolation and haemolytic characteristics of the carrier-free toxin. J. Gen. Microbiol. 132:307-315.
26. Lowry, P. N., and R. W. Quinn. 1964. Effect of hemolytic streptococci on tissue cells. Proc. Soc. Exp. Biol. Med. 116:46-51.
27. Madden, J. C., N. Ruiz, and M. Caparon. 2001. Cytolysin-mediated translocation (CMT): A functional equivalent of type III secretion in gram-positive bacteria. Cell 104:143-152.
28. Marcus, Z., A. M. Davies, and I. Ginsburg. 1965. Oxygen-stable hemolysins of group A streptococci. V. Effect on rat heart and kidney cells grown in tissue culture. Exp. Mol. Pathol. 4:93-107.
29. Moses, A. E., M. R. Wessels, K. Zalcman, S. A. Alberti, S. Natanson-Yaron, T. Menes, and E. Hanski. 1997. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of group A streptococci. Infect. Immun. 65:64-71.
30. Nizet, V., B. Beall, D. J. Bast, V. Datta, L. Kilburn, D. E. Low, and J. C. S. De Azavedo. 2000. Genetic locus for streptolysin S production by group A streptococci. Infect. Immun. 68:4245-4254.
31. O'Connor, S. P., and P. P. Cleary. 1987. In vivo Streptococcus pyogenes C5a peptidase activity: Analysis with transposon- and nitrosoguanidine-induced mutants. J. Infect. Dis. 156:495-504.
32. Ofek, I., S. Bergner-Rabinowitz, and I. Ginsberg. 1972. Oxygen-stable hemolysins of group A streptococci. 8. Leukotoxic and antiphagocytic effects of streptolysins S and O. Infect. Immun. 6:459-464.
33. Perez-Casal, J., J. A. Price, E. Maguin, and J. R. Scott. 1993. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: Use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol. Microbiol. 8:809-819.
34. Quinn, R. W., and P. N. Lowry. 1967. Effect of Streptococcus pyogenes on tissue cells. J. Bacteriol. 93:1825-1831.
35. Rheinwald, J. G., and M. A. Beckett. 1981. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res. 41:1657-1663.
36. Ruiz, N., B. Wang, A. Pentland, and M. Caparon. 1998. Streptolysin O and adherence synergistically modulate proinflammatory responses of keratinocytes to group A streptococci. Mol. Microbiol. 27:337-346.
37. Schrager, H., and M. R. Wessels. 1996. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J. Clin. Investig. 98:1954-1958.
38. Sharkawy, A., D. E. Low, R. Saginur, D. Gregson, B. Schwartz, P. Jessamine, K. Green, and A. McGeer. 2002. Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. Clin. Infect. Dis. 34:454-460.
39. Snyder, I. S., and T. R. Hamilton. 1963. Effect of streptolysin S on mammalian cells. J. Pathol. Bacteriol. 86:242-247.
40. Stevens, D. L. 1996. Invasive group A streptococcal disease. Infect. Agents Dis. 5:157-166.
41. Stocks, S. C., M. H. Ruchaud-Sparagano, M. A. Kerr, F. Grunert, C. Haslett, and I. Dransfield. 1996. CD66: Role in the regulation of neutrophil effector function. Eur. J. Immunol. 26:2924-2932.
42. Wessels, M. R., A. E. Moses, J. B. Goldberg, and T. J. DiCesare. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. USA 88:8317-8321.